How to Choose the Right Matrix for Validation Studies

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

Choose surrogate matrices when the true clinical matrix is scarce, hazardous, or impractical, but verify matrix equivalence through parallelism and recovery experiments.
Use pooled human matrix for routine validation when individual donor variation could obscure assay performance, and use individual donor matrices when you must characterize matrix effects across the population.
Document every matrix decision with supporting data, because regulatory reviewers and journal editors require evidence that the chosen matrix does not bias analytical results.

At a Glance

The table below summarizes the primary matrix options for validation studies, their typical applications, and the key considerations that should drive your selection.

Matrix Type	Best Suited For	Key Advantages	Primary Limitations
Surrogate matrix	Assays where the true matrix is unavailable, hazardous, or impractical to obtain	Consistent composition, easier to source, reduced biosafety burden	May not replicate all matrix effects, requires equivalence demonstration
Pooled human matrix	Routine validation, batch-to-batch consistency, quality control	Reduces individual donor variability, provides a stable reference	May mask rare matrix effects, requires careful pooling and mixing
Individual donor matrices	Evaluating matrix effects, interference testing, population variability	Reveals donor-specific effects, supports robustness assessment	More labor intensive, requires more samples, higher cost

Understanding Matrix Selection in Assay Validation

Matrix selection is a foundational decision in assay validation because the matrix is the environment in which the analyte is measured. The matrix includes all components of a biological sample other than the analyte of interest, such as proteins, lipids, salts, and cellular debris. These components can influence the analytical signal, the extraction efficiency, and the stability of the analyte. When you validate an assay, you are also validating the method itself but also the method as it operates within a specific matrix. A method that performs well in one matrix may perform poorly in another, and the validation data you generate are only meaningful for the matrix you actually tested.

The practical problem is that the ideal matrix for validation is the same matrix that will be used in routine testing. For a clinical diagnostic assay, that means human serum, plasma, urine, or another human biological fluid. For a veterinary assay, it means the corresponding animal matrix. For an environmental assay, it means the relevant water, soil, or air sample. In many cases, the true matrix is available in sufficient quantity and quality to support validation. In other cases, it is not. The matrix may be scarce, expensive, hazardous, or difficult to obtain in the volumes needed for a full validation study. This is where surrogate matrices become relevant.

The decision framework presented here is based on the principle that the matrix you choose must be fit for purpose. Fit for purpose means that the matrix supports the intended use of the assay and that you have data to demonstrate this. The framework also recognizes that regulatory guidance and laboratory standards require you to document your matrix selection and to justify it with evidence. The National Library of Medicine provides access to authoritative laboratory-method references that describe the principles of assay validation and the importance of matrix selection. These references are a useful starting point for understanding the scientific basis of matrix selection.

The Role of the Matrix in Assay Performance

The matrix can affect the assay in several ways. First, the matrix can interfere with the detection step. For example, in a colorimetric assay, the color of the matrix itself may contribute to the background signal. In a fluorescence assay, the matrix may contain compounds that quench the fluorescence. In a mass spectrometry assay, the matrix can cause ion suppression or enhancement, which changes the signal intensity for the same amount of analyte. These effects are matrix-specific, and they can vary from one donor to another.

Second, the matrix can affect the extraction and recovery of the analyte. If the assay includes a sample preparation step, such as protein precipitation, liquid-liquid extraction, or solid-phase extraction, the matrix can influence the efficiency of that step. The analyte may bind to matrix components, or the matrix may cause the analyte to be lost during the extraction. Recovery is typically measured by spiking a known amount of analyte into the matrix and measuring the amount that is recovered after the sample preparation.

Third, the matrix can affect the stability of the analyte. Some analytes are unstable in certain matrices, and the matrix can accelerate or slow the degradation of the analyte. This is particularly important for assays that measure labile compounds, such as proteins, peptides, or nucleic acids. The matrix can also affect the stability of the analyte during storage, which is relevant for the validation of sample handling and storage conditions.

Fourth, the matrix can affect the specificity of the assay. The matrix may contain compounds that are structurally similar to the analyte and that cross-react with the assay. This is a particular concern for immunoassays, where the antibody may bind to matrix components that are not the target analyte. The matrix can also contain compounds that inhibit the assay, such as inhibitors of the polymerase chain reaction in a molecular assay.

The Role of the Matrix in the Validation Study

The validation study is designed to demonstrate that the assay is suitable for its intended use. The validation typically includes assessments of accuracy, precision, sensitivity, specificity, and stability. Each of these assessments is performed in the matrix. The accuracy of the assay is determined by measuring the recovery of known amounts of the analyte spiked into the matrix. The precision is determined by measuring the variability of the assay when it is performed multiple times on the same sample. The sensitivity is determined by measuring the lowest concentration of the analyte that can be reliably detected. The specificity is determined by measuring the ability of the assay to distinguish the analyte from other compounds.

The matrix is therefore a central component of the validation. If the matrix is not representative of the samples that will be tested, the validation results may not be applicable to the real-world samples. This is why the choice of matrix is so important. The matrix must be representative of the samples that will be tested, and the validation must be performed in that matrix.

The Role of the Matrix in the Validation

The matrix is also important for the interpretation of the validation results. The validation results are used to establish the performance characteristics of the assay, such as the limit of detection, the limit of quantification, and the reportable range. These characteristics are matrix-specific. The limit of detection in one matrix may be different from the limit of detection in another matrix. The validation results are therefore only valid for the matrix in which they were generated.

This is why the choice of matrix is so important. The matrix must be representative of the samples that will be tested, and the validation must be performed in the matrix. If the matrix is not representative, the validation results may not be applicable to the real-world samples.

Core Principles of Matrix Selection

Assay Type and Matrix Compatibility

The first principle of matrix selection is that the matrix must be compatible with the assay type. Different assay types have different requirements for the matrix. For example, a molecular assay that uses the polymerase chain reaction requires a matrix that does not contain inhibitors of the polymerase. A mass spectrometry assay requires a matrix that does not cause ion suppression. An immunoassay requires a matrix that does not contain cross-reacting compounds.

The compatibility of the matrix with the assay is determined by the assay's performance in the matrix. This is typically assessed during the validation, but it can also be assessed during the method development. The method development is the stage where the assay is designed and optimized. During this stage, the matrix is often tested to determine whether it is compatible with the assay. If the matrix is not compatible, the assay may need to be modified, or a different matrix may need to be selected.

The compatibility of the matrix with the assay is also determined by the assay's intended use. The assay may be intended for use with a specific type of sample, such as serum or plasma. In this case, the matrix must be the same type of sample. The assay may also be intended for use with a specific population, such as a particular species or a particular age group. In this case, the matrix must be representative of that population.

Matrix Availability and Practicality

The second principle of matrix selection is that the matrix must be available in sufficient quantity and quality for the validation. The validation requires a large number of samples, and the matrix must be available in the required volumes. The matrix must also be of sufficient quality, meaning that it is not contaminated, degraded, or otherwise unsuitable for the assay.

The availability of the matrix is a practical consideration. Some matrices are readily available, such as human serum or plasma from blood banks. Other matrices are scarce, such as cerebrospinal fluid or certain tissue samples. The scarcity of the matrix can affect the cost of the validation and the time required to complete the validation.

The quality of the matrix is also a practical consideration. The matrix must be collected, processed, and stored in a way that preserves its integrity. The matrix must be free of contaminants that could interfere with the assay. The matrix must also be stable during storage, which may require the use of preservatives or the storage at specific temperatures.

Regulatory and Guidance Considerations

The third principle of matrix selection is that the matrix must meet the regulatory and guidance requirements for the assay. The regulatory requirements depend on the intended use of the assay. For a clinical diagnostic assay, the regulatory requirements are set by the Food and Drug Administration (FDA) in the United States. For a research-use-only assay, the regulatory requirements are less stringent.

The regulatory requirements for the matrix are typically described in the guidance documents for the assay. These documents may specify the type of matrix that must be used for the validation. They may also specify the number of matrix lots that must be tested, the number of donors that must be included, and the acceptance criteria for the matrix.

The regulatory requirements for the matrix are also determined by the intended use of the assay. The assay may be intended for use with a specific type of sample, such as a particular type of blood sample. In this case, the matrix must be the same type of sample. The assay may also be intended for use with a range of samples, such as samples from different species. In this case, the matrix must be representative of that range.

Surrogate Matrices

Definition and Rationale

A surrogate matrix is a matrix that is used in place of the true matrix. The surrogate matrix is typically a simpler matrix, such as a buffer or a synthetic matrix, that is designed to mimic the properties of the true matrix. The surrogate matrix is used when the true matrix is unavailable, scarce, or difficult to work with.

The rationale for using a surrogate matrix is that it allows the validation to be performed when the true matrix is not available. The surrogate matrix can be used to develop the assay, to optimize the assay, and to validate the assay. The surrogate matrix can also be used to reduce the cost of the validation, as the surrogate matrix is often less expensive than the true matrix.

The surrogate matrix is also used when the true matrix is hazardous. For example, the true matrix may contain infectious agents, and the surrogate matrix may be safer to work with. The surrogate matrix is also used when the true matrix is difficult to obtain, such as when the matrix is from a rare or endangered species.

Types of Surrogate Matrices

There are several types of surrogate matrices. The most common type is a buffer, such as phosphate-buffered saline (PBS) or a similar buffer. The buffer is a simple matrix that does not contain the components of the true matrix. The buffer is used when the assay is not affected by the matrix components.

Another type of surrogate matrix is a synthetic matrix, such as a synthetic protein or a synthetic lipid. The synthetic matrix is designed to mimic the properties of the true matrix. The synthetic matrix is used when the assay is affected by the matrix components.

Another type of surrogate matrix is a matrix from a different species. For example, a matrix from a different species may be used as a surrogate for a human matrix. The matrix from a different species is used when the human matrix is not available.

The Use of Surrogate Matrices

The use of surrogate matrices is a common practice in assay validation. The surrogate matrix is used to provide the validation when the true matrix is not available. The surrogate matrix is also used to reduce the cost of the validation.

The use of surrogate matrices is also a common practice in the development of the assay. The surrogate matrix is used to develop the assay, to optimize the assay, and to validate the assay. The surrogate matrix is also used to test the assay's performance.

The use of surrogate matrices is a common practice in the validation of the assay. The surrogate matrix is used to validate the assay's performance. The surrogate matrix is also used to validate the assay's stability.

The Limitations of Surrogate Matrices

The use of surrogate matrices has limitations. The surrogate matrix may not be representative of the true matrix. The surrogate matrix may not contain the components of the true matrix, which may affect the assay's performance. The surrogate matrix may also not be stable, which may affect the assay's performance.

The use of surrogate matrices is also limited by the need to demonstrate equivalence. The surrogate matrix must be shown to be equivalent to the true matrix. The equivalence is typically demonstrated by comparing the assay's performance in the surrogate matrix to the assay's performance in the true matrix. The equivalence is also demonstrated by comparing the assay's performance in the surrogate matrix to the assay's performance in the true matrix.

The use of surrogate matrices is also limited by the need to demonstrate the equivalence. The equivalence is typically demonstrated by comparing the assay's performance in the surrogate matrix to the assay's performance in the true matrix. The equivalence is also demonstrated by comparing the assay's performance in the surrogate matrix to the assay's performance in the true matrix.

Pooled Human Matrix

Definition and Preparation

A pooled human matrix is a matrix that is prepared by combining samples from multiple donors. The pooled matrix is used to provide a representative matrix for the validation. The pooled matrix is also used to reduce the variability of the matrix.

The pooled matrix is prepared by combining samples from multiple donors. The samples are typically combined in equal volumes, but the volumes may be adjusted to achieve a specific concentration of the matrix. The pooled matrix is then mixed thoroughly to ensure that the matrix is homogeneous.

The pooled matrix is stored in a way that ensures the matrix's integrity. The pooled matrix is typically stored in aliquots, which are frozen or refrigerated. The pooled matrix is also stored in a way that prevents contamination.

Advantages of Pooled Human Matrix

The pooled human matrix has several advantages. The pooled matrix reduces the variability of the matrix. The pooled matrix is a representative matrix, which is used to provide a representative matrix for the validation. The pooled matrix is also a convenient matrix, which is used to provide a convenient matrix for the validation.

The pooled matrix is also a cost-effective matrix. The pooled matrix is less expensive than the individual donor matrices. The pooled matrix is also a time-saving matrix, which is used to save time in the validation.

The pooled matrix is also a consistent matrix. The pooled matrix is a consistent matrix, which is used to provide a consistent matrix for the validation. The pooled matrix is also a reliable matrix, which is used to provide a reliable matrix for the validation.

Limitations of Pooled Human

The pooled human has several limitations. The pooled human matrix does not reveal the variability of the matrix. The pooled human matrix is a representative matrix, but it does not reveal the variability of the matrix. The pooled human matrix is also a matrix that is not the true matrix, which may affect the assay's performance.

The pooled human matrix is also a matrix that is not the true matrix. The pooled human matrix is a matrix that is not the true matrix, which may affect the assay's performance. The pooled human matrix is also a matrix that is not the true matrix, which may affect the assay's performance.

Individual Donor Matrices

Definition and Purpose

An individual donor matrix is a matrix that is prepared from a single donor. The individual donor matrix is used to provide a matrix that is representative of the individual donor. The individual donor matrix is also used to evaluate the variability of the matrix.

The individual donor matrix is prepared from a single donor. The individual donor matrix is used to provide a matrix that is representative of the individual donor. The individual donor matrix is also used to evaluate the variability of the matrix.

The individual donor matrix is used to evaluate the variability of the matrix. The individual donor matrix is used to evaluate the variability of the matrix. The individual donor matrix is also used to evaluate the variability of the matrix.

Advantages of Individual Donor Matrices

The individual donor matrix has several advantages. The individual donor matrix is a matrix that is representative of the individual donor. The individual donor matrix is also a matrix that is used to evaluate the variability of the matrix.

The individual donor matrix is also a matrix that is used to evaluate the variability of the matrix. The individual donor matrix is also a matrix that is used to evaluate the variability of the matrix. The individual donor matrix is also a matrix that is used to evaluate the variability of the matrix.

Limitations of Individual Donor Matrices

The individual donor matrix has several limitations. The individual donor matrix is a matrix that is not the same as the pooled matrix. The individual donor matrix is a matrix that is not the same as the pooled matrix. The individual donor matrix is also a matrix that is not the same as the pooled matrix.

The individual donor matrix is also a matrix that is not the same as the pooled matrix. The individual donor matrix is also a matrix that is not the same as the pooled matrix. The individual donor matrix is also a matrix that is not the same as the pooled matrix.

Decision Framework for Matrix Selection

Step 1: Define the Assay and Its Intended Use

The first step in the decision framework is to define the assay and its intended use. The assay is defined by its purpose, its target, and its sample type. The intended use is defined by the population, the setting, and the regulatory requirements.

The assay is defined by its purpose. The purpose of the assay is to detect or quantify the analyte. The assay is also defined by its type, such as a molecular assay, an immunoassay, or a mass spectrometry assay. The assay is also defined by its sample type, such as the serum, the plasma, or the urine.

The intended use is defined by the population. The population is the group of individuals who will be tested. The intended use is also defined by the setting, such as the clinical setting or the research setting. The intended use is also defined by the regulatory requirements, such as the requirements for the clinical diagnostic assay.

Step 2: Determine the Availability of the True Matrix

The second step is to determine the availability of the true matrix. The true matrix is the matrix that will be used in the real-world samples. The availability of the true matrix is determined by the quantity, the quality, and the cost of the matrix.

The quantity of the true matrix is determined by the volume of the matrix that is available. The quantity of the true matrix is also determined by the number of donors that are available. The quantity of the true matrix is also determined by the frequency of the collection.

The quality of the true matrix is determined by the quality of the matrix. The quality of the matrix is determined by the contamination, the degradation, and the stability of the matrix. The quality of the matrix is also determined by the storage and the handling of the matrix.

The cost of the true matrix is determined by the cost of the matrix. The cost of the matrix is determined by the cost of the collection, the cost of the processing, and the cost of the storage.

Step 3: Evaluate the Matrix Compatibility

The third step is to evaluate the matrix compatibility. The matrix compatibility is the compatibility of the matrix with the assay. The matrix compatibility is determined by the assay's performance in the matrix.

The matrix compatibility is evaluated by testing the assay's performance in the matrix. The assay's performance is evaluated by the sensitivity, the specificity, the accuracy, and the precision of the assay. The assay's performance is also evaluated by the recovery of the analyte.

The matrix compatibility is also evaluated by the matrix's effect on the assay. The matrix's effect is evaluated by the matrix's interference, the matrix's inhibition, and the matrix's enhancement.

Step 4: Consider the Regulatory Requirements

The fourth step is to consider the regulatory requirements. The regulatory requirements are the requirements for the assay. The regulatory requirements are determined by the intended use of the assay.

The regulatory requirements are determined by the intended use of the assay. The regulatory requirements are also determined by the regulatory agency. The regulatory requirements are also determined by the guidance documents.

Step 5: Select the Matrix

The fifth step is to select the matrix. The matrix is selected based on the availability, the compatibility, and the regulatory requirements. The matrix is also selected based on the cost and the practicality.

The matrix is selected based on the availability. The matrix is selected based on the availability of the matrix. The matrix is also selected based on the quality of the matrix.

The matrix is selected based on the compatibility. The matrix is selected based on the compatibility of the matrix with the assay. The matrix is also selected based on the compatibility of the matrix with the intended use.

The matrix is selected based on the regulatory requirements. The matrix is selected based on the regulatory requirements for the assay. The matrix is also selected based on the regulatory requirements for the intended use.

Practical Implementation Steps

Step 1: Document the Matrix Selection

The first step is to document the matrix selection. The documentation should include the rationale for the matrix selection, the data that supports the matrix selection, and the limitations of the matrix selection.

The documentation should include the rationale for the matrix selection. The rationale should describe the reasons for the matrix selection. The rationale should also describe the alternatives that were considered.

The documentation should include the data that supports the matrix selection. The data should include the results of the compatibility testing, the results of the equivalence testing, and the results of the validation.

The documentation should include the limitations of the matrix selection. The limitations should describe the limitations of the matrix selection. The limitations should also describe the potential impact of the limitations.

Step 2: Prepare the Matrix

The second step is to prepare the matrix. The preparation of the matrix includes the collection, the processing, and the storage of the matrix.

The collection of the matrix includes the collection of the matrix from the donors. The collection of the matrix also includes the collection of the matrix from the environment.

The processing of the matrix includes the processing of the matrix. The processing of the matrix includes the pooling, the mixing, and the aliquoting of the matrix.

The storage of the matrix includes the storage of the matrix. The storage of the matrix includes the storage of the matrix at the appropriate temperature, the storage of the matrix in the appropriate container, and the storage of the matrix for the appropriate duration.

Step 3: Perform the Validation

The third step is to perform the validation. The validation includes the assessment of the assay's performance. The validation also includes the assessment of the matrix's performance.

The validation includes the assessment of the assay's performance. The assay's performance is assessed by the accuracy, the precision, the sensitivity, the specificity, and the stability of the assay.

The validation also includes the assessment of the matrix's performance. The matrix's performance is assessed by the matrix's effect on the assay. The matrix's effect is assessed by the interference, the inhibition, and the enhancement of the matrix.

Step 4: Document the Validation Results

The fourth step is to document the validation results. The documentation includes the results of the validation. The documentation also includes the interpretation of the results.

The documentation includes the results of the validation. The results include the results of the accuracy, the precision, the sensitivity, the specificity, and the stability of the assay.

The documentation also includes the interpretation of the results. The interpretation includes the interpretation of the results in the context of the intended use.

Step 5: Review and Approve the Validation

The fifth step is to review and approve the validation. The review includes the review of the validation results. The review also includes the review of the documentation.

The review includes the review of the validation results. The review also includes the review of the documentation. The review also includes the review of the matrix selection.

The approval includes the approval of the validation. The approval also includes the approval of the matrix selection.

Records and Measurements

Records to Maintain

The records to maintain include the records of the matrix selection, the records of the matrix preparation, and the records of the validation.

The records of the matrix selection include the rationale for the matrix selection, the data used for the matrix selection, and the limitations of the matrix selection.

The records of the matrix preparation include the collection of the matrix, the processing of the matrix, and the storage of the matrix.

The records of the validation include the results of the validation, the interpretation of the results, and the approval of the validation.

Measurements to Record

The measurements to record include the measurements of the matrix, the measurements of the assay, and the measurements of the validation.

The measurements of the matrix include the measurements of the matrix's composition, the matrix's concentration, and the matrix's stability.

The measurements of the assay include the measurements of the assay's accuracy, the assay's precision, the assay's sensitivity, the assay's specificity, and the assay's stability.

The measurements of the validation include the measurements of the validation's results, the validation's interpretation, and the validation's limitations.

Common Failure Patterns

Failure to Demonstrate Equivalence

A common failure pattern is the failure to demonstrate equivalence. The equivalence is the equivalence between the surrogate matrix and the true matrix. The equivalence is also the equivalence between the pooled matrix and the individual donor matrix.

The failure to demonstrate equivalence is a common failure pattern. The failure to demonstrate equivalence is a common failure pattern because the equivalence is not always demonstrated. The equivalence is not always demonstrated because the equivalence is not always tested.

The failure to demonstrate equivalence is a common failure pattern. The failure to demonstrate equivalence is a common failure because the equivalence is not always demonstrated. The equivalence is not always demonstrated because the equivalence is not always tested.

Failure to Document the Matrix Selection

The common failure pattern is the failure to document the matrix selection. The documentation is the documentation of the matrix selection. The documentation is also the documentation of the rationale for the matrix selection.

The failure to document the matrix selection is a common failure pattern. The failure to document the matrix selection is a common failure because the documentation is not always performed. The documentation is not always performed because the documentation is not always required.

The failure to document the matrix selection is a common failure. The failure to document the matrix selection is a common failure because the documentation is not always performed. The documentation is not always performed because the documentation is not always required.

Failure to Use the Appropriate Matrix

The common failure pattern is the failure to use the appropriate matrix. The appropriate matrix is the matrix that is appropriate for the assay. The appropriate matrix is also the matrix that is appropriate for the intended use.

The failure to use the appropriate matrix is a common failure pattern. The failure to use the appropriate matrix is a common failure because the appropriate matrix is not always used. The appropriate matrix is not always used because the appropriate matrix is not always available.

The failure to use the appropriate matrix is a common failure. The failure to use the appropriate matrix is a common failure because the appropriate matrix is not always used. The appropriate matrix is not always used because the appropriate matrix is not always available.

Quality and Safety Considerations

Quality Control

The quality control is the quality control of the matrix. The quality control is also the quality control of the assay. The quality control is also the quality control of the validation.

The quality control of the matrix includes the quality control of the matrix's composition, the matrix's concentration, and the matrix's stability.

The quality control of the assay includes the quality control of the assay's accuracy, the assay's precision, the assay's sensitivity, the assay's specificity, and the assay's stability.

The quality control of the validation includes the quality control of the validation's results, the validation's interpretation, and the validation's limitations.

Biosafety

The biosafety is the biosafety of the matrix. The biosafety is also the biosafety of the assay. The biosafety is also the biosafety of the validation.

The biosafety of the matrix includes the biosafety of the matrix's collection, the matrix's processing, and the matrix's storage.

The biosafety of the assay includes the biosafety of the assay's performance. The biosafety of the assay also includes the biosafety of the assay's reagents.

The biosafety of the validation includes the biosafety of the validation's procedures. The biosafety of the validation also includes the biosafety of the validation's waste.

The biosafety principles are described in the Biosafety in Microbiological and Biomedical Laboratories, which is provided by the CDC and the NIH. The biosafety principles include the risk assessment, the containment, and the institutional oversight.

Professional Escalation Criteria

The professional escalation criteria are the criteria for escalating the matrix selection to a professional. The professional escalation criteria are also the criteria for escalating the validation to a professional.

The professional escalation criteria include the criteria for escalating the matrix selection. The criteria include the criteria for escalating the matrix selection when the matrix is not available, when the matrix is not compatible, and when the matrix is not appropriate.

The professional escalation criteria include the criteria for escalating the validation. The criteria include the criteria for escalating the validation when the validation fails, when the validation is not complete, and when the validation is not acceptable.

The professional escalation criteria also include the criteria for escalating the matrix selection to a professional. The criteria include the criteria for escalating the matrix selection when the matrix is not available, when the matrix is not compatible, and when the matrix is not appropriate.

Frequently Asked Questions

What is the difference between a surrogate matrix and a pooled human matrix?

A surrogate matrix is a matrix that is used in place of the true matrix. The surrogate matrix is typically a simpler matrix, such as a buffer or a synthetic matrix. A pooled human matrix is a matrix that is prepared by pooling samples from multiple donors. The pooled human matrix is a representative matrix that is used to reduce the variability of the matrix.

When should I use a surrogate matrix?

You should use a surrogate matrix when the true matrix is not available, when the true matrix is scarce, or when the true matrix is difficult to work with. You should also use a surrogate matrix when the true matrix is hazardous. The surrogate matrix should be shown to be equivalent to the true matrix.

When should I use a pooled human matrix?

You should use a pooled human matrix when you need a representative matrix for the validation. You should also use a pooled human matrix when you need to reduce the variability of the matrix. The pooled human matrix is a convenient and cost-effective matrix.

When should I use individual donor matrices?

You should use individual donor matrices when you need to evaluate the variability of the matrix. You should also use individual donor matrices when you need to evaluate the matrix effects. The individual donor matrices are used to evaluate the matrix effects of the individual donors.

How do I demonstrate equivalence between a surrogate matrix and the true matrix?

You demonstrate equivalence by comparing the assay's performance in the surrogate matrix to the assay's performance in the true matrix. The equivalence is demonstrated by comparing the accuracy, the precision, the sensitivity, and the specificity of the assay in the two matrices.

What are the regulatory requirements for matrix selection?

The regulatory requirements for matrix selection are determined by the intended use of the assay. The regulatory requirements are also determined by the regulatory agency. The regulatory requirements are also determined by the guidance documents.

What are the common failure patterns in matrix selection?

The common failure patterns in matrix selection include the failure to demonstrate equivalence, the failure to document the matrix selection, and the failure to use the appropriate matrix. These failure patterns can be avoided by following the decision framework and the practical steps.

What are the biosafety considerations for matrix selection?

The biosafety considerations for matrix selection include the biosafety of the matrix, the biosafety of the assay, and the biosafety of the validation. The biosafety principles are described in the CDC and NIH guidelines. The biosafety principles include the risk assessment, the containment, and the institutional oversight.

Using the Evidence

Source	Best use in this topic	Important limitation
Molecular Biology and Laboratory Methods	official guidance	Check the linked page for current local requirements
Biosafety in Microbiological and Biomedical Laboratories	official guidance	Check the linked page for current local requirements
NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules	official guidance	Check the linked page for current local requirements

Related Diagnostic Guides

References and Further Reading

Molecular Biology and Laboratory Methods. National Library of Medicine.
Biosafety in Microbiological and Biomedical Laboratories. CDC and NIH.
NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules. National Institutes of Health.
Addgene Protocols. Addgene.
MIQE Guidelines. Clinical Chemistry.
NIST Laboratory Programs. National Institute of Standards and Technology.
Laboratory Biosafety Manual. World Health Organization.
NCBI Literature Resources. National Center for Biotechnology Information.
Anti-drug Antibody Validation Testing and Reporting Harmonization.. The AAPS journal, 2021.
Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS.. Analytical chemistry, 2003.
Validation of an evaluation matrix for the nursing process in the hospital context.. Revista gaucha de enfermagem, 2024.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.